✦ LIBER ✦

Activation and inhibition of the fibrinolytic system in cancer patients after isolated limb perfusion with tumor necrosis factor a, (interferon γ) and melphalan

✍ Scribed by V.J.J. Bom; J.H. Zwaveling; A.R.J. Girbes; R.J. van Ginkel; H.Schraffordt Koops; J. van der Meer

Book ID: 119154635
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 138 KB
Volume: 8
Category: Article
ISSN: 0268-9499
DOI: 10.1016/0268-9499(94)90607-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isolated limb reperfusion with tumor nec

Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics

✍ David L. Bartlett; Grace Ma; H. Richard Alexander; Steven K. Libutti; Douglas L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Background: This retrospective study evaluated the benefit of using tumor necrosis factor (tnf) and melphalan administered via an isolated limb perfusion (ilp) in a series of patients with metastatic melanoma who failed initial ilp with chemotherapeutics. ## Methods: Seventeen patients with ex

Absence of Severe Systemic Toxicity Afte

Absence of Severe Systemic Toxicity After Leakage-Controlled Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan

✍ Bart C. Vrouenraets; Bin B. R. Kroon; Aernout C. Ogilvie; Albert N. van Geel; Om 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 94 KB

Complications of combined radiotherapy a

Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha ± interferon gamma and melphalan in patients with irresectable soft tissue tumors

✍ Vrouenraets, Bart C.; Keus, Ronald B.; Nieweg, Omgo E.; Kroon, Bin B. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Background: Isolated limb perfusion (ilp) with tumor necrosis factor alpha (tnf alpha) +/-interferon gamma (ifn gamma) and melphalan in patients with primarily irresectable soft tissue sarcoma is promising in terms of tumor regression and limb salvage. however, the feasibility of radiotherapy in

Treatment of primary or relapsing limb c

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan

✍ Maurizio Vaglini; Filiberto Belli; Mario Ammatuna; Maria Grazia Inglese; Renato 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 834 KB

Efficacy of Repeat Isolated Limb Perfusi

Efficacy of Repeat Isolated Limb Perfusions With Tumor Necrosis Factor α and Melphalan for Multiple In-Transit Metastases in Patients with Prior Isolated Limb Perfusion Failure

✍ Dirk J. Grünhagen; Boudewijn van Etten; Flavia Brunstein; Wilfried J. Graveland; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 106 KB

Isolated limb perfusion with tumor necro

Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

✍ Eva M. Noorda; Bart C. Vrouenraets; Omgo E. Nieweg; Frits van Coevorden; Gooike 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using